Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Detection of Impending Aggressive Outbursts in Patients with Psychiatric Disorders: Violence Clues from Dogs.

Bakeman U, Eilam H, Schild CM, Grinstein D, Eshed Y, Laster M, Fride E, Anavi-Goffer S.

Sci Rep. 2019 Nov 21;9(1):17228. doi: 10.1038/s41598-019-52940-w.

2.

Blocking the postpartum mouse dam's CB1 receptors impairs maternal behavior as well as offspring development and their adult social-emotional behavior.

Schechter M, Pinhasov A, Weller A, Fride E.

Behav Brain Res. 2012 Jan 15;226(2):481-92. doi: 10.1016/j.bbr.2011.10.016. Epub 2011 Oct 15.

PMID:
22020200
3.

Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy.

Bregman T, Fride E.

J Basic Clin Physiol Pharmacol. 2011 Jun 17;22(1-2):33-6. doi: 10.1515/jbcpp.2011.005.

PMID:
22865361
4.

Treatment with tetrahydrocannabinol (THC) prevents infertility in male cystic fibrosis mice.

Bregman T, Fride E.

J Basic Clin Physiol Pharmacol. 2011 Jun 17;22(1-2):29-32. doi: 10.1515/jbcpp.2011.004.

PMID:
22865360
5.

The endocannabinoid system during development: emphasis on perinatal events and delayed effects.

Fride E, Gobshtis N, Dahan H, Weller A, Giuffrida A, Ben-Shabat S.

Vitam Horm. 2009;81:139-58. doi: 10.1016/S0083-6729(09)81006-6. Review.

PMID:
19647111
6.

Examining maternal influence on OLETF rats' early overweight: insights from a cross-fostering study.

Schroeder M, Schechter M, Fride E, Moran TH, Weller A.

Dev Psychobiol. 2009 May;51(4):358-66. doi: 10.1002/dev.20374.

7.

Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation.

Patinkin D, Milman G, Breuer A, Fride E, Mechoulam R.

Eur J Pharmacol. 2008 Oct 24;595(1-3):1-6. doi: 10.1016/j.ejphar.2008.05.002. Epub 2008 May 15.

PMID:
18778813
8.

Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain.

Moussaieff A, Rimmerman N, Bregman T, Straiker A, Felder CC, Shoham S, Kashman Y, Huang SM, Lee H, Shohami E, Mackie K, Caterina MJ, Walker JM, Fride E, Mechoulam R.

FASEB J. 2008 Aug;22(8):3024-34. doi: 10.1096/fj.07-101865. Epub 2008 May 20.

9.

Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development.

Fride E.

J Neuroendocrinol. 2008 May;20 Suppl 1:75-81. doi: 10.1111/j.1365-2826.2008.01670.x. Review.

PMID:
18426504
10.

Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation.

Moussaieff A, Shohami E, Kashman Y, Fride E, Schmitz ML, Renner F, Fiebich BL, Munoz E, Ben-Neriah Y, Mechoulam R.

Mol Pharmacol. 2007 Dec;72(6):1657-64. Epub 2007 Sep 25.

PMID:
17895408
11.

Inhibition of milk ingestion and growth after administration of a neutral cannabinoid CB1 receptor antagonist on the first postnatal day in the mouse.

Fride E, Braun H, Matan H, Steinberg S, Reggio PH, Seltzman HH.

Pediatr Res. 2007 Nov;62(5):533-6.

PMID:
17805201
12.

Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness.

Gobshtis N, Ben-Shabat S, Fride E.

Eur J Pharmacol. 2007 Jan 12;554(2-3):155-63. Epub 2006 Oct 19.

PMID:
17116301
13.

Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling.

Tam J, Ofek O, Fride E, Ledent C, Gabet Y, Müller R, Zimmer A, Mackie K, Mechoulam R, Shohami E, Bab I.

Mol Pharmacol. 2006 Sep;70(3):786-92. Epub 2006 Jun 13.

PMID:
16772520
14.

Endocannabinoids, feeding and suckling--from our perspective.

Mechoulam R, Berry EM, Avraham Y, Di Marzo V, Fride E.

Int J Obes (Lond). 2006 Apr;30 Suppl 1:S24-8. Review.

PMID:
16570101
15.

Behavioral methods in cannabinoid research.

Fride E, Perchuk A, Hall FS, Uhl GR, Onaivi ES.

Methods Mol Med. 2006;123:269-90.

PMID:
16506414
16.

Endocannabinoids in the central nervous system: from neuronal networks to behavior.

Fride E.

Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):633-42. Review.

PMID:
16375681
17.

Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice.

Fride E, Suris R, Weidenfeld J, Mechoulam R.

Behav Pharmacol. 2005 Sep;16(5-6):431-40.

PMID:
16148448
18.

The Jerusalem Balsam: from the Franciscan Monastery in the old city of Jerusalem to Martindale 33.

Moussaieff A, Fride E, Amar Z, Lev E, Steinberg D, Gallily R, Mechoulam R.

J Ethnopharmacol. 2005 Oct 3;101(1-3):16-26.

PMID:
15963667
19.

Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.

Fride E, Ponde D, Breuer A, Hanus L.

Neuropharmacology. 2005 Jun;48(8):1117-29. Epub 2005 Apr 26.

PMID:
15910887
20.

Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood.

Fride E, Bregman T, Kirkham TC.

Exp Biol Med (Maywood). 2005 Apr;230(4):225-34. Review.

PMID:
15792943
21.

Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors.

Hanus LO, Tchilibon S, Ponde DE, Breuer A, Fride E, Mechoulam R.

Org Biomol Chem. 2005 Mar 21;3(6):1116-23. Epub 2005 Feb 16.

PMID:
15750656
22.

(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.

Fride E, Feigin C, Ponde DE, Breuer A, Hanus L, Arshavsky N, Mechoulam R.

Eur J Pharmacol. 2004 Dec 15;506(2):179-88.

PMID:
15588739
23.

Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility.

Maccarrone M, Fride E, Bisogno T, Bari M, Cascio MG, Battista N, Finazzi Agrò A, Suris R, Mechoulam R, Di Marzo V.

Mol Hum Reprod. 2005 Jan;11(1):21-8. Epub 2004 Nov 23.

PMID:
15563449
24.

The endocannabinoid-CB(1) receptor system in pre- and postnatal life.

Fride E.

Eur J Pharmacol. 2004 Oct 1;500(1-3):289-97. Review.

PMID:
15464041
25.

The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.

Fride E.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):24-30. Review.

PMID:
15159678
26.

A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.

Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M.

Arthritis Rheum. 2004 Mar;50(3):985-98.

27.

Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.

Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R.

Eur J Pharmacol. 2003 Feb 7;461(1):27-34.

PMID:
12568912
28.

The endocannabinoid system: function in survival of the embryo, the newborn and the neuron.

Fride E, Shohami E.

Neuroreport. 2002 Oct 28;13(15):1833-41. Review.

PMID:
12395075
29.

Endocannabinoids in the central nervous system--an overview.

Fride E.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):221-33. Review.

PMID:
12052038
30.

Lipids in neural function: modulation of behavior by oral administration of endocannabinoids found in foods.

Crozier Willi G, Berger A, Di Marzo V, Bisogno T, De Petrocellis L, Fride E, Mechoulam R.

Nestle Nutr Workshop Ser Clin Perform Programme. 2001;5:169-84; discussion 185-7. Review. No abstract available.

PMID:
11510437
31.

Critical role of the endogenous cannabinoid system in mouse pup suckling and growth.

Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R.

Eur J Pharmacol. 2001 May 11;419(2-3):207-14.

PMID:
11426843
32.

Physiology. A hunger for cannabinoids.

Mechoulam R, Fride E.

Nature. 2001 Apr 12;410(6830):763, 765. No abstract available.

PMID:
11298428
33.

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.

Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3662-5. Epub 2001 Mar 20.

34.

Towards cannabinoid drugs--revisited.

Mechoulam R, Hanus L, Fride E.

Prog Med Chem. 1998;35:199-243. Review. No abstract available.

PMID:
10795402
35.

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.

Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E.

Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14228-33.

36.

Trick or treat from food endocannabinoids?

Di Marzo V, Sepe N, De Petrocellis L, Berger A, Crozier G, Fride E, Mechoulam R.

Nature. 1998 Dec 17;396(6712):636-7. No abstract available.

37.

Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid.

Mechoulam R, Fride E, Ben-Shabat S, Meiri U, Horowitz M.

Eur J Pharmacol. 1998 Nov 27;362(1):R1-3.

PMID:
9865537
38.

Endocannabinoids.

Mechoulam R, Fride E, Di Marzo V.

Eur J Pharmacol. 1998 Oct 16;359(1):1-18. Review.

PMID:
9831287
39.

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity.

Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R.

Eur J Pharmacol. 1998 Jul 17;353(1):23-31.

PMID:
9721036
40.

Biphasic effects of anandamide.

Sulcova E, Mechoulam R, Fride E.

Pharmacol Biochem Behav. 1998 Feb;59(2):347-52.

PMID:
9476980
41.

Anandamide may mediate sleep induction.

Mechoulam R, Fride E, Hanus L, Sheskin T, Bisogno T, Di Marzo V, Bayewitch M, Vogel Z.

Nature. 1997 Sep 4;389(6646):25-6. No abstract available.

PMID:
9288961
42.

Endogenous cannabinoid ligands--chemical and biological studies.

Mechoulam R, Ben Shabat S, Hanus L, Fride E, Vogel Z, Bayewitch M, Sulcova AE.

J Lipid Mediat Cell Signal. 1996 Sep;14(1-3):45-9. Review.

PMID:
8906544
43.

Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice.

Fride E, Mechoulam R.

Brain Res Dev Brain Res. 1996 Aug 20;95(1):131-4.

PMID:
8873985
44.

Developmental aspects of anandamide: ontogeny of response and prenatal exposure.

Fride E, Mechoulam R.

Psychoneuroendocrinology. 1996 Feb;21(2):157-72.

PMID:
8774060
45.

Cannabinoids: receptors, endogenous ligands and a newly synthesized antagonist.

Barth F, Mechoulam R, Fride E, Deadwyler S, Martin B.

NIDA Res Monogr. 1996;162:52-3. No abstract available.

PMID:
9066812
46.

Endogenous cannabinoid ligands.

Mechoulam R, Shabat SB, Hanus L, Fride E, Bayewitch M, Vogel Z.

Adv Exp Med Biol. 1996;402:95-101. Review. No abstract available.

PMID:
8787649
47.

Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides.

Barg J, Fride E, Hanus L, Levy R, Matus-Leibovitch N, Heldman E, Bayewitch M, Mechoulam R, Vogel Z.

Eur J Pharmacol. 1995 Dec 12;287(2):145-52.

PMID:
8749028
48.

Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol.

Fride E.

Brain Res. 1995 Oct 30;697(1-2):83-90.

PMID:
8593598
49.

Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol.

Fride E, Barg J, Levy R, Saya D, Heldman E, Mechoulam R, Vogel Z.

J Pharmacol Exp Ther. 1995 Feb;272(2):699-707.

PMID:
7853184
50.

Immunocompetence in the long sleep and short sleep mouse lines: baseline versus primed responses.

Fride E, McIntyre T, Skolnick P, Arora PK.

Brain Behav Immun. 1993 Sep;7(3):231-42.

PMID:
8219412

Supplemental Content

Support Center